Pharmacogenomics Research Network (U01/U19)

Post Date

January 30th 2009

Application Due Date

June 2nd 2009

Funding Opportunity Number

RFA-GM-10-001

CFDA Number(s)

93.209
93.242
93.279
93.393
93.394
93.395
93.396
93.837
93.838
93.839
93.859

Funding Instrument Type(s)

Cooperative Agreement

Funding Activity Categories

Education
Health

Eligibility Categories

Public and State Controlled Institutions of Higher Education
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs).

Funding

• Estimated Total Funding:

  $30000000

• Award Range:

  $None - $None

Grant Description

Purpose. The purpose of this funding opportunity announcement issued by NIGMS, NHLBI, NCI, NIDA, NIMH, and NICHD is to allow new and renewal applications for research groups to compete to become part of the Pharmacogenomics Research Network (PGRN), and to create network resources that serve the entire PGRN. The PGRN is a consortium of interdisciplinary groups with a core mission to conduct research into understanding the genetic basis of variable drug responses, both therapeutic and adverse. The scientific objectives of the research network include definition of the pressing problems for safe and effective use of medications, establishment of truly cross-disciplinary research groups, application of the most appropriate genetic and genomic methods to important sample collections, discovery and replication studies that identify variation in critical genes and biological pathways, elucidation of the functional consequences of genetic variation for the drugs being studied, and understanding the clinical implications of genotyping to predict drug responses

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/rfa-files/RFA-GM-10-001.html